NOVA LABORATORIES LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Moore

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Significant events

• “During the year, we took out a bank loan, and also used a proportion of our cash reserves, to fund a dividend of £24m which was paid to our parent company in order to facilitate a buyback of all minority shareholdings. This resulted in net assets falling from £52m in 2024 to £35m at the year end.”
• “During the year, we launched our 4th licensed product, Qaialdo, in February.”
• “During the year, we also completed the first part of new production facility, and commenced the second part this will assist us as our product portfolio expands and we move into new markets.”
• “Our 2nd automated filling line is expected to be ready for use in early 2026.”
• “Subsequent to the year end, the intercompany loan balance of £6m due to Nova Bio-Pharma Holdings Limited was fully repaid on 31 October 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +3.7%

  £39,311,345 → £40,777,629

• Cash

  -94.9%

  £12,879,781 → £662,231

• Net assets

  -34.2%

  £52,501,979 → £34,544,990

• Employees

  +6.7%

  254 → 271

• Operating profit

  -23.6%

  £10,834,210 → £8,274,520

• Profit before tax

  -28.7%

  £10,487,336 → £7,475,213

• Wages

  +8.3%

  £11,059,230 → £11,973,024

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers